Vivoryon Therapeutics N.V. (VVY.AS)

EUR 1.9

(-1.04%)

Gross Profit Summary of Vivoryon Therapeutics N.V.

  • Vivoryon Therapeutics N.V.'s latest annual gross profit in 2023 was -3.09 Million EUR , down -1896.89% from previous year.
  • Vivoryon Therapeutics N.V.'s latest quarterly gross profit in 2024 Q2 was -73 Thousand EUR , down 0.0% from previous quarter.
  • Vivoryon Therapeutics N.V. reported a annual gross profit of -161 Thousand EUR in annual gross profit 2022, down -101.78% from previous year.
  • Vivoryon Therapeutics N.V. reported a annual gross profit of 9.03 Million EUR in annual gross profit 2021, up 6284.93% from previous year.
  • Vivoryon Therapeutics N.V. reported a quarterly gross profit of -3.21 Million EUR for 2023 FY, down -1896.89% from previous quarter.
  • Vivoryon Therapeutics N.V. reported a quarterly gross profit of -79 Thousand EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Gross Profit Chart of Vivoryon Therapeutics N.V. (2023 - 2011)

Historical Annual Gross Profit of Vivoryon Therapeutics N.V. (2023 - 2011)

Year Gross Profit Gross Profit Growth
2023 -3.09 Million EUR -1896.89%
2022 -161 Thousand EUR -101.78%
2021 9.03 Million EUR 6284.93%
2020 -146 Thousand EUR -65.91%
2019 -88 Thousand EUR -282.61%
2018 -23 Thousand EUR 78.3%
2017 -106 Thousand EUR -9.28%
2016 -97 Thousand EUR -73.21%
2015 -56 Thousand EUR 0.0%
2014 - EUR 0.0%
2013 - EUR -100.0%
2012 6000.00 EUR -71.43%
2011 21 Thousand EUR 0.0%

Peer Gross Profit Comparison of Vivoryon Therapeutics N.V.

Name Gross Profit Gross Profit Difference
ABIONYX Pharma SA 618 Thousand EUR 600.809%
ABIVAX Société Anonyme 3.91 Million EUR 179.075%
Adocia SA 1.38 Million EUR 323.466%
Aelis Farma SA 12.35 Million EUR 125.045%
Biophytis S.A. -803 Thousand EUR -285.43%
Advicenne S.A. 1.42 Million EUR 317.041%
genOway Société anonyme 20.1 Million EUR 115.398%
IntegraGen SA 5.01 Million EUR 161.675%
Medesis Pharma S.A. -2.66 Million EUR -16.145%
Neovacs S.A. 29.31 Thousand EUR 10658.095%
NFL Biosciences SA -56.06 Thousand EUR -5420.477%
Plant Advanced Technologies SA 2.15 Million EUR 243.758%
Quantum Genomics Société Anonyme -1.41 Million EUR -118.067%
Sensorion SA 3.78 Million EUR 181.708%
Theranexus Société Anonyme -4.63 Million EUR 33.279%
TME Pharma N.V. -127 Thousand EUR -2337.008%
Valbiotis SA 2.66 Million EUR 216.004%
TheraVet SA -530.79 Thousand EUR -483.087%
Valerio Therapeutics Société anonyme 1.26 Million EUR 344.278%
argenx SE 925.49 Million EUR 100.334%
BioSenic S.A. 543 Thousand EUR 669.982%
Celyad Oncology SA 33 Thousand EUR 9478.788%
DBV Technologies S.A. 4.15 Million EUR 174.406%
Galapagos NV 203.73 Million EUR 101.519%
Genfit S.A. 28.22 Million EUR 110.966%
GeNeuro SA -293.8 Thousand EUR -953.438%
Hyloris Pharmaceuticals SA 1.99 Million EUR 255.216%
Innate Pharma S.A. -4.12 Million EUR 24.897%
Inventiva S.A. 17.5 Million EUR 117.686%
MaaT Pharma SA 1.65 Million EUR 287.009%
MedinCell S.A. 9.28 Million EUR 133.323%
Nanobiotix S.A. 36.2 Million EUR 108.548%
Onward Medical N.V. -14.81 Million EUR 79.113%
Oryzon Genomics S.A. 13.94 Million EUR 122.19%
OSE Immunotherapeutics SA 2.22 Million EUR 238.976%
Oxurion NV 104 Thousand EUR 3075.962%
Pharming Group N.V. 220.1 Million EUR 101.406%
Poxel S.A. 1000.00 EUR 309600.0%
GenSight Biologics S.A. 3 Million EUR 203.167%
Transgene SA -28.4 Million EUR 89.104%
Financière de Tubize SA -2.02 Million EUR -52.494%
UCB SA 3.34 Billion EUR 100.093%
Valneva SE 52.83 Million EUR 105.858%